PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMadrigal Pharmaceuticals
Madrigal Pharmaceuticals(MDGL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Resmetirom
healthy volunteers/patients
,
hepatic insufficiency
,
renal insufficiency
,
heart failure
,
hyperlipoproteinemia type ii
,
alcoholic fatty liver
,
non-alcoholic fatty liver disease
,
liver diseases
,
fibrosis
,
liver cirrhosis
,
fatty liver
,
hyperlipidemias
,
dyslipidemias
,
thyroid hormone resistance syndrome
Ganetespib
carcinoma
,
multiple myeloma
,
male breast neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
leukemia
,
myeloid leukemia acute
,
precursor cell lymphoblastic leukemia-lymphoma
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia chronic-phase
,
myeloid leukemia
,
blast crisis
,
lymphoid leukemia
,
myeloproliferative disorders
,
neoplasms
,
breast neoplasms
,
rectal neoplasms
,
small cell lung carcinoma
,
melanoma
,
gastrointestinal stromal tumors
,
sarcoma
,
neurofibrosarcoma
,
nerve sheath neoplasms
,
colonic neoplasms
,
triple negative breast neoplasms
,
uveal neoplasms
,
lung neoplasms
,
non-small-cell lung carcinoma
Elesclomol
prostatic neoplasms
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
non-small-cell lung carcinoma
,
sarcoma
,
neoplasm metastasis
,
neoplasms
,
melanoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use